Research Memo: Loss of Subsidized Drug Coverage and Mortality Following Medicaid Disenrollment: Translating our Findings and Implications for Medicaid Policy
Supplement to Response to Request for Technical Assistance
Opioid Epidemic
Policy
Comment: Opportunities to Improve Substance Use Disorder Care in the Federal Health Programs
Submitted to U.S. Senate Committee on Finance
Print:
On April 23, 2024, the Leonard Davis Institute of Health Economics Substance Use and Harm Reduction Working Group submitted a statement regarding the United States Senate Committee on Finance’s recent hearing “Closing Gaps in the Care Continuum: Opportunities to Improve Substance Use Disorder Care in the Federal Health Programs.” Their comment makes recommendations for improvement in several areas of the care continuum which deserve urgent attention, such as reimbursement for care in a wide range of settings and for certified recovery specialists, improved methadone access, improved wound care and support for harm reduction services.
More on Policy at LDI
Research Memo: Medicaid’s Role in Health and the Health Care Landscape: Key Takeaways from LDI Researchers
Delivered to Staff of U.S. Senate Committee on Finance
Testimony: Restricting Youth Access to Nicotine and Tobacco Products
Delivered to Philadelphia City Council
Briefing: Nursing Home Staffing Mandate and Resident Outcomes
Presented to Staff of U.S. Senate Committee on Finance
Comment: Studies from Penn LDI on Medicare Post-Acute Care
Submitted to the U.S. Committee on Ways & Means Subcommittee on Health
Briefing: Health Implications of the Supplemental Nutrition Assistance Program (SNAP)
Presented to Staff of Rep. GT Thompson (R-PA)